Home > Insider Trading > Filing (0001567619-22-014300)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1501989	Cytomx Therapeutics Inc.	CTMX	Pharmaceutical Preparations (2834)	273521219

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1918615	B Jeffrey Landau	C/O Cytomx Therapeutics, Inc. 151 Oyster Point Blvd., Suite 400 South San Francisco CA 94080	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-07-19	11,250	$0.00	34,931	No	4	A	Direct
Common Stock	Disposition	2022-07-20	4,206	$1.42	30,725	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,500	Indirect	Fidelity Traditional IRA
Common Stock	3,180	Indirect	Schwab ROTH IRA

Footnotes

Represents Performance Stock Units ("PSUs") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested.
Includes 16,274 restricted stock units.
Reflects the adjusted total which includes the purchase of 5,040 shares under the Cytomx Therapeutics Employee Stock Purchase Plan on May 31, 2022.
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer.